EUVIMEDEUVIMED entdecken
Kohortenstudie

Serum Ferritin Levels and Liver‐Related Events in Individuals With Steatotic Liver Disease: A Longitudinal Cohort Study

Byeong Geun Song iD, Myung Ji Goh, Wonseok Kang iD, Geum-Youn Gwak iD, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn iD

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.18402 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Byeong Geun Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Ferritins, Fatty Liver, Biomarkers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Serum ferritin has been suggested as a potential biomarker associated with disease progression in metabolic dysfunction–associated steatotic liver disease (MASLD).

Aims

We investigated the association between serum ferritin levels and liver‐related events (LREs) in individuals with steatotic liver disease (SLD).

Methods

This cohort study included 17,560 adults with SLD (MASLD [ n = 15,744], MASLD with increased alcohol intake (MetALD) [ n = 1103] and cryptogenic SLD [ n = 713]) without LRE at baseline. A steatotic liver was diagnosed using ultrasound, and LRE was defined as the development of decompensation (ascites, variceal bleeding and hepatic encephalopathy) or hepatocellular carcinoma. Participants were categorised into high (≥ 300 μg/L for males, ≥ 200 μg/L for females) or normal to low (< 300 μg/L for males, < 200 μg/L for females) ferritin levels.

Results

During 211,425 person‐years of follow‐up (median: 12.3 years), 74 incident LRE cases were identified, with 63 cases in MASLD, 10 in MetALD and 1 in cryptogenic SLD. The multivariable‐adjusted hazard ratio (aHR) for LRE comparing individuals with high and normal‐to‐low ferritin level was 3.13 (95% confidence interval [CI] 1.89–5.18). Increased risk of LRE in individuals with high serum ferritin level compared to those with normal to low serum ferritin level was consistent across SLD subtypes (aHR 2.69, 95% CI 1.55–4.67 for MASLD; aHR 5.73, 95% CI 1.31–25.0 for MetALD), and SLD severity assessed by Fibrosis‐4 (FIB‐4) index (aHR 2.38, 95% CI 1.34–4.21 for FIB‐4 ≥ 1.3; aHR 3.13, 95% CI 1.18–8.29 for FIB‐4 < 1.3).

Conclusions

Serum ferritin levels correlated with the risk of LRE in patients with SLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerritinsFatty LiverBiomarkersHumansMaleFemaleMiddle AgedLongitudinal StudiesAdultAgedCohort StudiesLiver NeoplasmsRisk FactorsCarcinoma, HepatocellularDisease Progression

Stichwörter der Autor:innen

ferritinmetabolic dysfunction–associated steatotic liver diseasesteatotic liver disease

Substanzen

FerritinsBiomarkers

Autor:innen und Institutionen

  • Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

ORCID-Profile: Byeong Geun Song, Wonseok Kang, Geum-Youn Gwak, Dong Hyun Sinn

Zitieren

APA

Song, B. G., Goh, M. J., Kang, W., Gwak, G. Y., Paik, Y. H., Choi, M. S., Lee, J. H., & Sinn, D. H. (2025). Serum Ferritin Levels and Liver‐Related Events in Individuals With Steatotic Liver Disease: A Longitudinal Cohort Study. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18402

Vancouver

Song BG, Goh MJ, Kang W, Gwak GY, Paik YH, Choi MS, et al. Serum Ferritin Levels and Liver‐Related Events in Individuals With Steatotic Liver Disease: A Longitudinal Cohort Study. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.18402

BibTeX
@article{Song2025,
  author = {Song, Byeong Geun and Goh, Myung Ji and Kang, Wonseok and Gwak, Geum-Youn and Paik, Yong-Han and Choi, Moon Seok and Lee, Joon Hyeok and Sinn, Dong Hyun},
  title = {Serum Ferritin Levels and Liver‐Related Events in Individuals With Steatotic Liver Disease: A Longitudinal Cohort Study},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.18402}
}
Kostenlos starten →